Advances in clinical trial design for development of new TB treatments: A call for innovation
- PMID: 30901322
- PMCID: PMC6430361
- DOI: 10.1371/journal.pmed.1002769
Advances in clinical trial design for development of new TB treatments: A call for innovation
Abstract
Christian Lienhardt and Payam Nahid launch the Collection on Advances in Clinical Trial Design for Development of New Tuberculosis Treatments.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- Lienhardt C, Raviglione M, Spigelman M, Hafner R, Jaramillo E, Hoelscher M, et al. New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future. J Infect Dis. 2012;205 Suppl 2:S241–9. - PubMed
-
- Grosset J. Bacteriologic basis of short-course chemotherapy for tuberculosis. Clin Chest Med. 1980;1(2):231–41. - PubMed
-
- World Health Organization. Guidelines for treatment of drug-susceptible tuberculosis and patient care, 2017 update. WHO/HTM/TB/2017.05. Geneva: World Health Organization; 2017.
-
- Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946–1986, with relevant subsequent publications. Int J Tuberc Lung Dis 1999;3 (Suppl):S231–S279. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
